Latest Dividends News

Pengana International Equities (ASX: PIA) posted a sharp 82% plunge in net profit for FY26, triggering a strategic board reshuffle and a capital management package including a special dividend and buy-back proposal.

Invex Therapeutics posted a $1.35 million net loss for FY2026, driven by expanded R&D efforts and a deepening collaboration with Tessara Therapeutics targeting neurological diseases including Alzheimer’s. The company renewed its orphan drug status in Europe and restructured its board during the year.

Advance ZincTek posted an 11% rise in FY26 profit before tax to $2.247 million on 12.6% higher sales, driven by AI integration and US market strength. The company is set to enter residential battery manufacturing in FY27, leveraging its zinc oxide expertise.

Microba Life Sciences delivered a mixed FY26, with overall revenue slipping 5.8% to $14.76 million and a statutory loss widening 38.7% to $20.7 million. The company’s strategic pivot to core microbiome testing paid off with a 92% surge in core testing revenue and record test volumes in Australia and the UK. Despite the headline loss, underlying loss improved 11% thanks to cost cuts and AI-driven efficiencies. Microba is gearing up for the October launch of its GI Navigator diagnostic and targeting cash flow break-even on a run-rate basis in calendar 2027.

Eneco Refresh Limited has posted a 6.8% increase in revenue to $17.73 million for FY2026, alongside a remarkable 2072% jump in comprehensive profit after tax to $446,000, driven by operational improvements and resilience amid market volatility.

Cadence Opportunities Fund (ASX: CDO) is offering eligible shareholders a chance to buy up to $30,000 of shares at a 3.5% discount to market price, following a 30.3% portfolio gain for FY26 and a 41% total shareholder return.

AMCIL posted a $6.9 million profit for FY2026 while its portfolio returned negative 10%, underperforming the ASX 200. The company cut dividends to 4.0 cents fully franked, reshuffled holdings, and welcomed Alison Gibson as new CEO.

WT Financial Group (ASX: WTL) posted six consecutive years of growth in FY2026, with net revenue rising 15.6% to $33.1 million and EBITDA up 19.5% to $8.2 million, underpinned by its adviser network expansion and capital partnerships.

Salter Brothers Emerging Companies Limited (ASX:SB2) swung to a $7.9 million loss for FY26, driven by a $10.5 million investment write-down, while maintaining dividend payments and extending its share buy-back program.

Simonds Group delivered a record net profit after tax of $10.5 million for FY26, driven by a 9.5% revenue rise to $729.1 million and strategic expansion including a Western Australia joint venture.

Ion Video Limited narrowed its loss to $4.52 million in FY2026, slashing operating costs and shifting focus to intellectual property licensing while strengthening its balance sheet and securing funding through to late 2027.

Verbrec Limited accelerated its growth trajectory in FY2026, driven by a strategic acquisition and divestment, delivering a 52% revenue increase and a near tripling of net profit.